BRPI0815067A2 - Compostos de biciclotactama substituída - Google Patents

Compostos de biciclotactama substituída

Info

Publication number: BRPI0815067A2
Authority: BR; Brazil
Prior art keywords: bicyclestate; compounds; replaced; replaced bicyclestate; bicyclestate compounds
Prior art date: 2007-08-02

Application number

BRPI0815067-2A2A

Other languages

English (en)

Inventor

Robert Lee Dow

Michael John Munchhof

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-08-02

Filing date

2008-07-22

Publication date

2015-02-10

2008-07-22 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2015-02-10 Publication of BRPI0815067A2 publication Critical patent/BRPI0815067A2/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Diabetes (AREA)
Cardiology (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Ophthalmology & Optometry (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Hospice & Palliative Care (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Child & Adolescent Psychology (AREA)
Neurology (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

BRPI0815067-2A2A 2007-08-02 2008-07-22 Compostos de biciclotactama substituída BRPI0815067A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US95350707P	2007-08-02	2007-08-02
PCT/IB2008/001963 WO2009016462A2 (en)	2007-08-02	2008-07-22	Substituted bicyclolactam compounds

Publications (1)

Publication Number	Publication Date
BRPI0815067A2 true BRPI0815067A2 (pt)	2015-02-10

Family

ID=39926534

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0815067-2A2A BRPI0815067A2 (pt)	2007-08-02	2008-07-22	Compostos de biciclotactama substituída

Country Status (34)

Country	Link
US (2)	US20090036425A1 (pt)
EP (1)	EP2185567B1 (pt)
JP (1)	JP4629808B2 (pt)
KR (1)	KR20100032443A (pt)
CN (1)	CN101772504A (pt)
AP (1)	AP2010005163A0 (pt)
AR (1)	AR067780A1 (pt)
AT (1)	ATE502948T1 (pt)
AU (1)	AU2008281545B2 (pt)
BR (1)	BRPI0815067A2 (pt)
CA (1)	CA2695291C (pt)
CL (1)	CL2008002227A1 (pt)
CO (1)	CO6251365A2 (pt)
CR (1)	CR11223A (pt)
CY (1)	CY1111628T1 (pt)
DE (1)	DE602008005757D1 (pt)
DK (1)	DK2185567T3 (pt)
DO (1)	DOP2010000046A (pt)
EA (1)	EA201000050A1 (pt)
EC (1)	ECSP109932A (pt)
ES (1)	ES2361716T3 (pt)
HN (1)	HN2008001191A (pt)
HR (1)	HRP20110335T1 (pt)
MA (1)	MA31580B1 (pt)
PA (1)	PA8791601A1 (pt)
PE (1)	PE20090897A1 (pt)
PL (1)	PL2185567T3 (pt)
PT (1)	PT2185567E (pt)
SI (1)	SI2185567T1 (pt)
TN (1)	TN2010000053A1 (pt)
TW (1)	TWI356059B (pt)
UA (1)	UA94833C2 (pt)
WO (1)	WO2009016462A2 (pt)
ZA (1)	ZA201000255B (pt)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2008523133A (ja)	2004-12-14	2008-07-03	アストラゼネカアクチボラグ	Ｄｇａｔ阻害剤としてのオキサジアゾール誘導体
US7749997B2 (en)	2005-12-22	2010-07-06	Astrazeneca Ab	Pyrimido [4,5-B] -Oxazines for use as DGAT inhibitors
EP2301923B1 (en)	2006-03-31	2016-06-08	Novartis AG	Pyridine derivatives as dgat inhibitors
ATE492541T1 (de)	2006-05-30	2011-01-15	Astrazeneca Ab	Substituierte 5-phenylamino-1,3,4-oxadiazol-2- ylcarbonylamino-4-phenoxycyclohexancarbonsäuren als inhibitoren von acetylcoenzym-a- diacylglycerolacyltransferase
SG173312A1 (en)	2006-06-23	2011-08-29	Abbott Lab	Cyclopropyl amine derivatives as histamin h3 receptor modulators
US9108948B2 (en) *	2006-06-23	2015-08-18	Abbvie Inc.	Cyclopropyl amine derivatives
AR066169A1 (es)	2007-09-28	2009-07-29	Novartis Ag	Derivados de benzo-imidazoles, utiles para trastornos asociados con la actividad de dgat
WO2010086820A1 (en) *	2009-02-02	2010-08-05	Pfizer Inc.	4-amino-5-oxo-7, 8-dihydropyrimido [5,4-f] [1,4] oxazepin-6 (5h) -yl) phenyl derivatives, pharmaceutical compositions and uses thereof
WO2010089685A1 (en) *	2009-02-03	2010-08-12	Pfizer Inc.	4-amino-7,8-dihydropyrido[4,3-d]pyrimidin-5(6h)-one derivatives
WO2010089686A1 (en) *	2009-02-04	2010-08-12	Pfizer Inc.	4-amino-7,8-dihydropyrido[4,3-d]pyrimidin-5(6h)-one derivatives
EP3366686B9 (en)	2009-03-20	2021-08-04	Metabasis Therapeutics, Inc.	Inhibitors of diacylglycerol o-acyltransferase 1 (dgat-1) and uses thereof
US9186353B2 (en)	2009-04-27	2015-11-17	Abbvie Inc.	Treatment of osteoarthritis pain
ME02330B (me)	2010-03-19	2016-06-20	Pfizer	Derivati 2,3-dihidro-1h-inden-1-il-2,7-diazaspir0[3.6]nonana i njihova upotreba kao antagonista ili inverznih agonista grelinskog receptora
WO2011121350A1 (en)	2010-04-01	2011-10-06	Astrazeneca Ab	4 -amino -7,8- dihydropyrimido [5, 4 - f] [1, 4] oxazepin- 5 ( 6h) - one based dgat1 inhibitors
WO2012037258A1 (en)	2010-09-16	2012-03-22	Abbott Laboratories	Processes for preparing 1,2-substituted cyclopropyl derivatives
HUE025078T2 (en)	2010-10-29	2016-01-28	Pfizer	N1 / N2-lactam-acetyl-CoA carboxylase inhibitors
WO2012112364A1 (en) *	2011-02-14	2012-08-23	Merck Sharp & Dohme Corp.	Lactam derivatives as dgat-1 inhibitors
WO2012122075A1 (en) *	2011-03-08	2012-09-13	Merck Sharp & Dohme Corp.	Lactam derivatives as dgat-1 inhibitors
SG194142A1 (en)	2011-04-22	2013-11-29	Pfizer	Pyrazolospiroketone derivatives for use as acetyl - coa carboxylase inhibitors
PL2707361T3 (pl)	2011-05-10	2018-01-31	Gilead Sciences Inc	Skondensowane związki heterocykliczne stosowane jako modulatory kanału sodowego
LT2710013T (lt)	2011-05-20	2016-09-12	Glaxosmithkline Intellectual Property (No. 2) Limited	Naujieji junginiai kaip diacilglicerolio aciltransferazės inhibitoriai
TWI622583B (zh)	2011-07-01	2018-05-01	基利科學股份有限公司	作為離子通道調節劑之稠合雜環化合物
NO3175985T3 (pt)	2011-07-01	2018-04-28
EP2731944A1 (en)	2011-07-15	2014-05-21	Pfizer Inc	Gpr 119 modulators
JP5647379B2 (ja)	2011-07-22	2014-12-24	ファイザー・インク	キノリニルグルカゴン受容体モジュレーター
EP2751116B1 (en)	2011-08-31	2016-10-12	Pfizer Inc	Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds
WO2013055910A1 (en)	2011-10-12	2013-04-18	Arena Pharmaceuticals, Inc.	Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2013068439A1 (en) *	2011-11-09	2013-05-16	Intervet International B.V.	4-amino-5-oxo-7,8-dihydropyrimido[5, 4 -f] [1, 4] oxazepine compounds as dgat1 inhibitors
MD20140044A2 (ro)	2011-11-11	2014-08-31	Pfizer Inc.	2-Tiopirimidinone şi utilizarea lor pentru tratamentul afecţiunilor cardiovasculare
CN104245696A (zh) *	2012-02-07	2014-12-24	凯诺斯医药公司	作为1型二酰基甘油o-酰基转移酶的抑制剂的化合物
AU2013245353A1 (en)	2012-04-06	2014-09-25	Pfizer Inc.	Diacylglycerol acyltransferase 2 inhibitors
US8889730B2 (en)	2012-04-10	2014-11-18	Pfizer Inc.	Indole and indazole compounds that activate AMPK
KR101472279B1 (ko) *	2012-04-25	2014-12-16	한국화학연구원	신규한 베타 알라닌 유도체, 약학적으로 허용가능한 염 및 이를 유효성분으로 함유하는 약제학적 조성물
CA2872154C (en)	2012-05-04	2016-08-23	Pfizer Inc.	Heterocyclic substituted hexahydropyrano [3,4-d] [1,3] thiazin-2-amine compounds as inhibitors of app, bace1 and bace2
MA37765A1 (fr)	2012-06-20	2017-04-28	Hoffmann La Roche	Composés de pyrazole substitués utilisés comme antagonistes de lpar
US9260455B2 (en)	2012-09-20	2016-02-16	Pfizer Inc.	Alkyl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
WO2014054053A1 (en)	2012-10-03	2014-04-10	Advinus Therapeutics Limited	Spirocyclic compounds, compositions and medicinal applications thereof
WO2014074668A1 (en)	2012-11-08	2014-05-15	Arena Pharmaceuticals, Inc.	Modulators of gpr119 and the treatment of disorders related thereto
US9796729B2 (en)	2012-11-23	2017-10-24	Glaxosmithkline Llc	Compounds as diacylglycerol acyltransferase inhibitors
RS58539B1 (sr) *	2012-11-23	2019-04-30	Glaxosmithkline Llc	Nova jedinjenja kao inhibitori diacilglicerin aciltransferaze
EP2931731A1 (en)	2012-12-11	2015-10-21	Pfizer Inc.	Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds as inhibitors of bace1
US9403846B2 (en)	2012-12-19	2016-08-02	Pfizer Inc.	Carbocyclic- and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
CA2897678A1 (en)	2013-02-13	2014-08-21	Pfizer Inc.	Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
US9233981B1 (en)	2013-02-15	2016-01-12	Pfizer Inc.	Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
WO2014140241A1 (en) *	2013-03-15	2014-09-18	Intervet International B.V.	Pyridine derivatives as dgat-1 inhibitors
CN104418866B (zh) *	2013-08-23	2018-10-16	青岛黄海制药有限责任公司	Dgat1抑制剂及其制备方法和用途
ES2665153T3 (es)	2013-10-09	2018-04-24	Pfizer Inc.	Antagonistas del receptor EP3 de prostaglandina
CR20160405A (es)	2014-03-17	2016-11-07	Pfizer	Inhibidores de diacilglicerol aciltransferasa 2
CA2944475C (en)	2014-04-04	2018-07-10	Pfizer Inc.	Bicyclic-fused heteroaryl or aryl compounds
CN106459088A (zh)	2014-04-10	2017-02-22	辉瑞公司	2‑氨基‑6‑甲基‑4，4a，5，6‑四氢吡喃并[3，4‑d][1，3]噻嗪‑8a(8H)‑基‑1，3‑噻唑‑4‑基酰胺
WO2016092413A1 (en)	2014-12-10	2016-06-16	Pfizer Inc.	Indole and indazole compounds that activate ampk
WO2016103097A1 (en)	2014-12-22	2016-06-30	Pfizer Inc.	Antagonists of prostaglandin ep3 receptor
SG11201708407TA (en)	2015-05-05	2017-11-29	Pfizer	2-thiopyrimidinones
WO2016193844A1 (en)	2015-05-29	2016-12-08	Pfizer Inc.	Novel heterocyclic compounds as inhibitors of vanin-1 enzyme
DK3310784T3 (da)	2015-06-17	2020-11-09	Pfizer	Tricykliske forbindelser og deres anvendelse som phosphodiesterasehæmmere
WO2016203335A1 (en)	2015-06-18	2016-12-22	Pfizer Inc.	Novel pyrido[2,3-b]pyrazinones as bet-family bromodomain inhibitors
BR112018002071A2 (pt)	2015-08-13	2018-09-18	Pfizer	compostos heteroarílicos ou arílicos fundidos bicíclicos
KR102029124B1 (ko)	2015-08-27	2019-10-07	화이자 인코포레이티드	Irak4 조정제로서의 비시클릭-융합된 헤테로아릴 또는 아릴 화합물
WO2017037567A1 (en)	2015-09-03	2017-03-09	Pfizer Inc.	Regulators of frataxin
EP3353183A1 (en)	2015-09-24	2018-08-01	Pfizer Inc	N-[2-(2-amino-6,6-disubstituted-4, 4a, 5, 6-tetrahydropyrano [3,4-d][1,3]thiazin-8a (8h)-yl) -1, 3-thiazol-4-yl]amides
WO2017051303A1 (en)	2015-09-24	2017-03-30	Pfizer Inc.	Tetrahydropyrano[3,4-d][1,3]oxazin derivatives and their use as bace inhibitors
WO2017051294A1 (en)	2015-09-24	2017-03-30	Pfizer Inc.	N-[2-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2h-1,2,4-thiadiazin-5-yl)-1,3-thiazol-4-yl] amides useful as bace inhibitors
MD3397631T2 (ro)	2015-12-29	2021-08-31	Pfizer	3-Azabiciclo[3.1.0] hexani substituiţi drept inhibitori de cetohexokinază
KR20190026902A (ko)	2016-07-14	2019-03-13	화이자 인코포레이티드	바닌-1 효소의 억제제로서의 신규 피리미딘 카르복스아미드
AR109179A1 (es)	2016-08-19	2018-11-07	Pfizer	Inhibidores de diacilglicerol aciltransferasa 2
CN108164548B (zh) *	2016-12-07	2020-09-08	四川大学	嘧啶并吗啉衍生物及其制备方法和用途
WO2019133445A1 (en)	2017-12-28	2019-07-04	Inception Ibd, Inc.	Aminothiazoles as inhibitors of vanin-1
IL281093B2 (en)	2018-08-31	2025-11-01	Pfizer	Combinations for treatment of nash/nafld and related diseases
WO2020102575A1 (en)	2018-11-16	2020-05-22	Inception Ibd, Inc.	Heterocyclic aminothiazoles and uses thereof
CA3140972C (en)	2019-05-20	2024-06-18	Pfizer Inc.	Combinations comprising benzodioxol as glp-1r agonists for use in the treatment of nash/nafld and related diseases
EP3990452A1 (en)	2019-06-28	2022-05-04	Pfizer Inc.	5-(thiophen-2-yl)-1h-tetrazole derivatives as bckdk inhibitors useful for treating various diseases
TW202115086A (zh)	2019-06-28	2021-04-16	美商輝瑞大藥廠	Bckdk抑制劑
TWI771766B (zh)	2019-10-04	2022-07-21	美商輝瑞股份有限公司	二醯基甘油醯基轉移酶２抑制劑
SMT202400344T1 (it)	2020-02-07	2024-11-15	Gasherbrum Bio Inc	Agonisti di glp-1 eterociclici
JP2022058085A (ja)	2020-02-24	2022-04-11	ファイザー・インク	ジアシルグリセロールアシルトランスフェラーゼ２阻害剤とアセチル－ＣｏＡカルボキシラーゼ阻害剤との組合せ
WO2023026180A1 (en)	2021-08-26	2023-03-02	Pfizer Inc.	Amorphous form of (s)-2-(5-((3-ethoxypyridin-2-yl)oxy)pyridin-3-yl)-n-(tetrahydrofuran-3- yl)pyrimidine-5-carboxamide
WO2023100061A1 (en)	2021-12-01	2023-06-08	Pfizer Inc.	3-phenyl-1-benzothiophene-2-carboxylic acid derivatives as branched-chain alpha keto acid dehydrogenase kinase inhibitors for the treatment of diabetes, kidney diseases, nash and heart failure
CN119255988A (zh)	2022-04-14	2025-01-03	加舒布鲁姆生物公司	杂环glp-1激动剂
EP4598908A1 (en)	2022-10-07	2025-08-13	Pfizer Inc.	Hsd17b13 inhibitors and/or degraders
WO2024118524A1 (en)	2022-11-28	2024-06-06	Cerevel Therapeutics, Llc	Azaindole compounds and their use as phosphodiesterase inhibitors
WO2024125602A1 (en)	2022-12-15	2024-06-20	Gasherbrum Bio, Inc.	Salts and solid forms of a compound having glp-1 agonist activity
CN120731201A (zh)	2022-12-16	2025-09-30	辉瑞公司	含3-氟-4-羟基苯甲酰胺的抑制剂和/或降解剂及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100887471B1 (ko) *	2002-01-18	2009-03-10	교린 세이야꾸 가부시키 가이샤	축합 바이사이클릭 피리미딘 유도체
NZ539952A (en) *	2002-11-22	2008-05-30	Japan Tobacco Inc	Fused bicyclic nitrogen-containing heterocyclic compounds for treating diabetes, obesity and syndrome X
JP2007519605A (ja) *	2004-01-30	2007-07-19	日本たばこ産業株式会社	食欲抑制薬
JP2006056881A (ja) *	2004-07-21	2006-03-02	Takeda Chem Ind Ltd	縮合環化合物
US7749997B2 (en) *	2005-12-22	2010-07-06	Astrazeneca Ab	Pyrimido [4,5-B] -Oxazines for use as DGAT inhibitors

2008
- 2008-07-17 US US12/174,820 patent/US20090036425A1/en not_active Abandoned
- 2008-07-22 HR HR20110335T patent/HRP20110335T1/hr unknown
- 2008-07-22 PL PL08788942T patent/PL2185567T3/pl unknown
- 2008-07-22 CN CN200880101674A patent/CN101772504A/zh active Pending
- 2008-07-22 WO PCT/IB2008/001963 patent/WO2009016462A2/en not_active Ceased
- 2008-07-22 DE DE602008005757T patent/DE602008005757D1/de active Active
- 2008-07-22 CA CA2695291A patent/CA2695291C/en not_active Expired - Fee Related
- 2008-07-22 JP JP2010518764A patent/JP4629808B2/ja not_active Expired - Fee Related
- 2008-07-22 DK DK08788942.4T patent/DK2185567T3/da active
- 2008-07-22 PT PT08788942T patent/PT2185567E/pt unknown
- 2008-07-22 AU AU2008281545A patent/AU2008281545B2/en not_active Expired - Fee Related
- 2008-07-22 ES ES08788942T patent/ES2361716T3/es active Active
- 2008-07-22 UA UAA201001078A patent/UA94833C2/ru unknown
- 2008-07-22 BR BRPI0815067-2A2A patent/BRPI0815067A2/pt not_active IP Right Cessation
- 2008-07-22 KR KR1020107002273A patent/KR20100032443A/ko not_active Ceased
- 2008-07-22 SI SI200830242T patent/SI2185567T1/sl unknown
- 2008-07-22 EA EA201000050A patent/EA201000050A1/ru unknown
- 2008-07-22 AT AT08788942T patent/ATE502948T1/de active
- 2008-07-22 EP EP08788942A patent/EP2185567B1/en active Active
- 2008-07-22 AP AP2010005163A patent/AP2010005163A0/en unknown
- 2008-07-29 CL CL2008002227A patent/CL2008002227A1/es unknown
- 2008-07-29 HN HN2008001191A patent/HN2008001191A/es unknown
- 2008-07-30 PA PA20088791601A patent/PA8791601A1/es unknown
- 2008-08-01 TW TW097129254A patent/TWI356059B/zh not_active IP Right Cessation
- 2008-08-01 PE PE2008001299A patent/PE20090897A1/es not_active Application Discontinuation
- 2008-08-01 AR ARP080103360A patent/AR067780A1/es not_active Application Discontinuation
2009
- 2009-01-22 US US12/357,544 patent/US7718645B2/en not_active Expired - Fee Related
2010
- 2010-01-13 ZA ZA2010/00255A patent/ZA201000255B/en unknown
- 2010-01-18 CR CR11223A patent/CR11223A/es not_active Application Discontinuation
- 2010-01-29 TN TNP2010000053A patent/TN2010000053A1/fr unknown
- 2010-02-01 CO CO10010179A patent/CO6251365A2/es not_active Application Discontinuation
- 2010-02-01 DO DO2010000046A patent/DOP2010000046A/es unknown
- 2010-02-02 EC EC2010009932A patent/ECSP109932A/es unknown
- 2010-02-02 MA MA32575A patent/MA31580B1/fr unknown
2011
- 2011-05-17 CY CY20111100479T patent/CY1111628T1/el unknown

Also Published As

Publication number	Publication date
CR11223A (es)	2010-02-04
US20090137551A1 (en)	2009-05-28
CL2008002227A1 (es)	2009-04-17
CN101772504A (zh)	2010-07-07
DOP2010000046A (es)	2010-03-31
AU2008281545A1 (en)	2009-02-05
AP2010005163A0 (en)	2010-02-28
WO2009016462A3 (en)	2009-03-26
CA2695291C (en)	2012-04-17
JP4629808B2 (ja)	2011-02-09
ATE502948T1 (de)	2011-04-15
ES2361716T3 (es)	2011-06-21
PA8791601A1 (es)	2009-12-16
CA2695291A1 (en)	2009-02-05
HRP20110335T1 (hr)	2011-06-30
US7718645B2 (en)	2010-05-18
ECSP109932A (es)	2010-03-31
CY1111628T1 (el)	2015-10-07
AU2008281545B2 (en)	2011-12-08
SI2185567T1 (sl)	2011-06-30
UA94833C2 (en)	2011-06-10
AR067780A1 (es)	2009-10-21
HN2008001191A (es)	2012-01-17
DE602008005757D1 (de)	2011-05-05
CO6251365A2 (es)	2011-02-21
WO2009016462A2 (en)	2009-02-05
PL2185567T3 (pl)	2011-07-29
DK2185567T3 (da)	2011-05-16
PE20090897A1 (es)	2009-08-06
TN2010000053A1 (fr)	2011-09-26
JP2010535190A (ja)	2010-11-18
KR20100032443A (ko)	2010-03-25
TW200916471A (en)	2009-04-16
ZA201000255B (en)	2011-03-30
MA31580B1 (fr)	2010-08-02
PT2185567E (pt)	2011-05-27
EA201000050A1 (ru)	2010-08-30
EP2185567B1 (en)	2011-03-23
US20090036425A1 (en)	2009-02-05
TWI356059B (en)	2012-01-11
EP2185567A2 (en)	2010-05-19

Publication	Publication Date	Title
BRPI0815067A2 (pt)	2015-02-10	Compostos de biciclotactama substituída
BRPI0815042A2 (pt)	2015-02-10	Compostos de pirazol
BRPI0813500A2 (pt)	2015-01-06	Compostos antivirais
BRPI0821086A2 (pt)	2014-10-07	Compostos inseticidas
BRPI0818380A2 (pt)	2014-10-07	Combinação de herbicida-protetor
EP2170350A4 (en)	2011-09-28	SUBSTITUTED IMIDAZOHETEROCYCLES
ATE542825T1 (de)	2012-02-15	Substituierte piperidino-dihydrothienopyrimidine
BRPI0815717A2 (pt)	2015-02-10	Compostos de imidazopirazina.
DK2288375T3 (da)	2012-05-21	Pegylerede insulin-lispro-forbindelser
BRPI0920707A2 (pt)	2015-12-29	compostos
DK2242759T3 (da)	2012-12-17	Forbindelser
BRPI0811264A2 (pt)	2014-11-04	Compostos
SMT201600045B (it)	2016-02-25	Composti tetraciclinici c7-fluoro sostituiti
BRPI0809996A2 (pt)	2014-10-14	Compostos
BRPI0806537A2 (pt)	2014-04-22	Indazóis substituídos por 5-piridinona
BRPI0811939A2 (pt)	2014-11-25	Tiazóis substituídos por heteroarila
BRPI0814424A2 (pt)	2015-01-06	Compostos heterociclila
DK2297162T3 (da)	2012-11-26	Forbindelser
BRPI0816512A2 (pt)	2015-03-24	Cartucho de tinta
BRPI0817149A2 (pt)	2015-03-31	Cartucho de tinta
BRPI0916432A2 (pt)	2016-02-16	compostos
BRPI0806506A2 (pt)	2014-04-22	Indazóis substituídos por 5-furopiridinona
BRPI0815181A2 (pt)	2015-03-31	Compostos
PT2792662T (pt)	2016-07-07	Compostos de morfinano
DK2206698T3 (da)	2012-08-27	Ethynylindolforbindelser

Legal Events

Date	Code	Title	Description
2015-12-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.
2016-03-29	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.